Johnson & Johnson Q2 Preview: Focus on tariff threat, MedTech softness
by
Contributor since / Followers
Contributor since / Followers
15 hours ago
Sundry Photography Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma
JNJ
J&J wins appeals court ruling against Teva and Viatris in patent dispute over neuro drug
by
Contributor since / Followers
Contributor since / Followers
7 days ago
CatLane/E+ via Getty Images A U.S. appeals court has sided with Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson seeks FDA nod for expanded use of Capylta
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Ekaterina79/iStock via Getty Images Johnson & Johnson (NYSE:JNJ) said on Tuesday that it is seeking
US judge halts Trump administration move to layoff HHS employees
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
MarioGuti/iStock via Getty Images A U.S. federal judge has put a stop to the Trump
Bristol Myers wins favorable FDA label updates for cell therapies Breyanzi and Abecma
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
hapabapa/iStock Editorial via Getty Images Bristol Myers Squibb (NYSE:BMY) announced that the U.S. FDA has
Johnson & Johnson reports positive results from Imaavy study
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Solskin Johnson & Johnson (NYSE:JNJ) on Monday reported new findings from an indirect treatment comparison
Incyte granted FDA label expansion for lymphoma therapy Monjuvi
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
Incyte (NASDAQ:INCY) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label
Biotech M&A market expected to rebound, but not IPO market
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
While access to capital funding remains elusive for many biotechs and the macroeconomic environment remains
Pharma sees expanding deals with Chinese companies
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
Big Pharma sees Chinese pharma and biotech companies as increasingly attractive to do deals with
Global pharma stocks down as Trump renews tariff threat
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
Chip Somodevilla/Getty Images News Major global pharmaceutical companies traded lower in the premarket on Tuesday